What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
CIK: 0001884931
Total reported value
$405.7M
$405.7M
18 檔
48.6%
The Q3 2025 SEC filing reveals that Whitefort Capital Management, LP held a total portfolio value of $405.7M, covering 18 public equity positions.
Whitefort Capital Management, LP executed strategic sector rebalancing during Q3 2025, establishing 3 new positions while fully exiting 3 holdings and trimming 3 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ABUS | Arbutus Biopharma CORP | Stock-Other | 17.90% | -1.12% | — | |
| 2 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 15.79% | -2.70% | -9.02% | |
| 3 | GNW | Genworth Financial Inc | Stock-Financials | 9.74% | -0.19% | +14.90% | |
| 4 | SPY | Ss Spdr S&p 500 ETF Trust-us | ETF-Large Cap & Growth | 7.88% | — | — | |
| 5 | JOYY | Joyy Inc-adr | Stock-Other | 7.01% | -0.50% | -55.74% | |
| 6 | OABI | Omniab Inc | Stock-Other | 6.73% | -0.38% | +38.90% | |
| 7 | CDZI | Cadiz Inc | Stock-Other | 5.56% | -1.66% | — | |
| 8 | BALY | Bally's CORP | Stock-Other | 4.41% | +1.29% | — | |
| 9 | TDAY | USA Today Co Inc | Stock-Other | 4.38% | -2.27% | +34.19% | |
| 10 | OPK 3.75 01-15-29Bond | Opko Health Inc | Bond | 4.25% | +0.04% | — | |
| 11 | LQDA | Liquidia CORP | Stock-Other | 4.08% | — | -54.39% | |
| 12 | GLD | Spdr Gold Shares | ETF-Commodities | 2.84% | -3.10% | EXIT | |
| 13 | SGRY | Surgery Partners Inc | Stock-Other | 2.37% | +0.53% | — | |
| 14 | IWM | Ishares Russell 2000 ETF | ETF-Small Cap | 2.36% | — | — | |
| 15 | OPK | Opko Health Inc | Stock-Other | 2.24% | +0.24% | +176.18% | |
| 16 | ✓ | Stock-Other | 1.30% | -0.15% | +57.44% | ||
| 17 | VATE | Innovate CORP | Stock-Other | 1.07% | +2.18% | — | |
| 18 | NNAVW | Nextnav Inc | Stock-Other | 0.08% | -0.09% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ABUS | Arbutus Biopharma CORP | +2.4% | — | Unchanged |
| 2 | OPK | Opko Health Inc | +1.4% | +176.18% | Add |
| 3 | CDZI | Cadiz Inc | +1.1% | — | Unchanged |
| 4 | TDAY | USA Today Co Inc | +0.8% | +34.19% | Add |
| 5 | GNW | Genworth Financial Inc | +0.3% | +14.90% | Add |
| 6 | ✓ | +0.3% | +57.44% | Add | |
| 7 | OABI | Omniab Inc | +0.1% | +38.90% | Add |
| 8 | NNAVW | Nextnav Inc | 0% | — | Unchanged |
| 9 | GLD | Spdr Gold Shares | -0.3% | — | Unchanged |
| 10 | VATE | Innovate CORP | -0.4% | — | Unchanged |
| 11 | OPK 3.75 01-15-29Bond | Opko Health Inc | -0.6% | — | Unchanged |
| 12 | ROIV | Roivant Sciences Ltd. | -0.6% | -9.02% | Trim |
| 13 | SGRY | Surgery Partners Inc | -0.7% | — | Unchanged |
| 14 | LQDA | Liquidia CORP | -2.1% | -54.39% | Trim |
| 15 | JOYY | Joyy Inc-adr | -10.5% | -55.74% | Trim |
| 16 | SPY | Ss Spdr S&p 500 ETF Trust-us | — | NEW | New buy |
| 17 | BALY | Bally's CORP | — | NEW | New buy |
| 18 | GSL | Global Ship Lease, Inc. | — | EXIT | Sold out |
| 19 | IWM | Ishares Russell 2000 ETF | — | NEW | New buy |
| 20 | VATE 7.5 08-01-26 *Bond | Innovate CORP | — | EXIT | Sold out |
| 21 | TRIB | Trinity Biotech Plc-spon Adr | — | EXIT | Sold out |
According to official SEC Form 13F filings, Whitefort Capital Management, LP reported a total U.S. public equity portfolio value of $405.7M across 18 disclosed positions in Q3 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including ABUS, ROIV, GNW) accounted for 48.6% of total reported equity market value during Q3 2025.
Top New Position Initiated
SPY
市值: $26.6M
Top Position Liquidated / Trimmed
GSL
前期市值: $9.3M
During Q3 2025, Whitefort Capital Management, LP's top holdings by market value included ABUS (17.9%)、ROIV (15.8%)、GNW (9.7%). The largest single position, ABUS, represented 17.9% of total portfolio value.
In Q3 2025, Whitefort Capital Management, LP made 14 total portfolio adjustments, initiating 3 new buys, adding to 5 positions, trimming 3 holdings, and fully liquidating 3 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.